Schedule 13G ownership disclosure

INVIVO THERAPEUTICS HOLDINGS CORP.

Security class unavailable · CUSIP: 46186M407

Event date: 2018-06-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
198,411
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-043038
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Jun 29, 2018
Reporting period
Jun 21, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub